FOURTH AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • October 1st, 2021 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
This Fourth Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of September 29, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and 1315 Capital II, L.P., a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).
Fourth AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • October 1st, 2021 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus
This Fourth Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of September 29, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and Ampersand 2018 Limited Partnership, a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).
